Lonza reported CHF8B in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Akzo Nobel EUR 8.41B 287M Sep/2026
Alcon AG USD 6.97B 350M Sep/2026
Almirall EUR 747.1M 33.12M Jun/2026
AstraZeneca USD 31.45B 3.48B Sep/2026
BASF EUR 35.21B 3.58B Sep/2026
Bayer EUR 39.6B 5.96B Sep/2026
Beiersdorf EUR 7.43B 768M Jun/2026
Covestro EUR 6.18B 271M Jun/2026
Demant DKK 10.2B 130M Jun/2026
Fresenius EUR 12.29B 678M Sep/2026
Fresenius Medical Care EUR 7.84B 150.6M Sep/2026
Geberit CHF 1.13B 151.3M Dec/2024
Genmab DKK 2.8B 228M Jun/2026
Givaudan CHF 4.07B 258M Dec/2025
GlaxoSmithKline GBP 17.9B 336M Sep/2026
GN Store Nord DKK 20.15B 14.52B Sep/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Johnson Matthey GBP 2.95B 985M Dec/2026
Merck EUR 15.14B 1.37B Sep/2026
Novartis USD 28.75B 1.4B Sep/2026
Philips EUR 10.51B 1.18B Sep/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sanofi EUR 33.21B 1.68B Sep/2026
Sika AG CHF 4.41B 242.1M Dec/2025
Smith & Nephew USD 4.39B 240M Jun/2026
Solvay EUR 2.19B 142M Sep/2026
UCB EUR 6.05B 733M Dec/2025